151 related articles for article (PubMed ID: 26797018)
1. Can Big Data Analyses Help Speed Up the Clinical Development of Mucoactive Drugs for Symptomatic RTIs?
Albrecht HH
Lung; 2016 Feb; 194(1):31-4. PubMed ID: 26797018
[TBL] [Abstract][Full Text] [Related]
2. Guaifenesin in rhinitis.
Storms W; Farrar JR
Curr Allergy Asthma Rep; 2009 Mar; 9(2):101-6. PubMed ID: 19210898
[TBL] [Abstract][Full Text] [Related]
3. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
4. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
5. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections.
Hoffer-Schaefer A; Rozycki HJ; Yopp MA; Rubin BK
Respir Care; 2014 May; 59(5):631-6. PubMed ID: 24003241
[TBL] [Abstract][Full Text] [Related]
6. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
[TBL] [Abstract][Full Text] [Related]
7. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.
Albrecht HH; Dicpinigaitis PV; Guenin EP
Multidiscip Respir Med; 2017; 12():31. PubMed ID: 29238574
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic modalities for the management of cough associated with acute respiratory viral infection, effective in an otolaryngologist's practice].
Ovchinnikov AI; Paniakina MA; Korostelev SA; Mitiuk AM
Vestn Otorinolaringol; 2014; (2):86-9. PubMed ID: 24781181
[TBL] [Abstract][Full Text] [Related]
10. Question: does guaifenesin improve outcomes in patients with cough associated with upper respiratory infection compared with no intervention?
Ramirez N; Jared M; Hodgden J; Toalson W
J Okla State Med Assoc; 2012 Oct; 105(10):397-8. PubMed ID: 23316675
[No Abstract] [Full Text] [Related]
11. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes to assess the efficacy of extended-release guaifenesin for the treatment of acute respiratory tract infection symptoms.
Albrecht H; Vernon M; Solomon G
Respir Res; 2012 Dec; 13(1):118. PubMed ID: 23270519
[TBL] [Abstract][Full Text] [Related]
13. Mucoactive drugs.
Balsamo R; Lanata L; Egan CG
Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
[TBL] [Abstract][Full Text] [Related]
14. Mucus and mucins.
Rubin BK
Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
[TBL] [Abstract][Full Text] [Related]
15. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
Prabhu Shankar S; Chandrashekharan S; Bolmall CS; Baliga V
J Indian Med Assoc; 2010 May; 108(5):313-4, 316-8, 320. PubMed ID: 21121410
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Ascoril in the management of cough--National Study Group report.
Ainapure SS; Desai A; Korde K
J Indian Med Assoc; 2001 Feb; 99(2):111, 114. PubMed ID: 11482804
[TBL] [Abstract][Full Text] [Related]
18. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
Del Donno M; Olivieri D
Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy.
Jeyakumar A; Brickman TM; Haben M
Laryngoscope; 2006 Dec; 116(12):2108-12. PubMed ID: 17146380
[TBL] [Abstract][Full Text] [Related]
20. [Results of international multicentre non-interventional clinical study of the effectiveness and safety of ascoril expectorant for the treatment of cough in Kazakhstan and Uzbekistan].
Nurgozhin TS; Guliaev AE; Ermekbaeva BA; Zhaugasheva SK; Abuova GT; An ÉA
Klin Med (Mosk); 2013; 91(6):50-5. PubMed ID: 24417069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
